Stanley Tennant is Director at Trovagene, Inc. (TROV). They have made 7 open-market trades across 1 company since 2012, most recently 2018-06-08.
CIK 0001526214
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $290K since 2012, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TROV | BUY | 2018-06-08 | 2018-06-13 | $0.80 | $8K | N/A | N/A | N/A |
| TROV | SELL | 2017-09-05 | 2017-09-06 | $0.69 | $6K | N/A | N/A | N/A |
| TROV | BUY | 2016-12-19 | 2016-12-19 | $2.10 | $21K | N/A | N/A | N/A |
| TROV | BUY | 2016-12-16 | 2016-12-19 | $2.00 | $30K | N/A | N/A | N/A |
| TROV | BUY | 2015-08-12 | 2015-08-12 | $6.06 | $61K | N/A | N/A | N/A |
| TROV | BUY | 2012-11-30 | 2012-12-03 | $4.82 | $121K | N/A | N/A | N/A |
| TROV | BUY | 2012-04-13 | 2012-04-16 | $0.50 | $50K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.